Study finds new designer drug is potent treatment for chronic myelogenous leukemia
A laboratory study led by researchers at Dana-Farber Cancer Institute has shown that a potent and highly selective therapy for chronic myelogenous leukemia (CML) may ultimately be more effective than GleevecŪ, the current standard of care... click link for more info.
Continue to Study finds new designer drug is potent treatment for chronic myelogenous leukemia on Medical News Today.
Medical Buzz delivers the most recent headlines from the medical world. Diseases, cures, accidents, medicin. Click below for more headlines ...
Medical buzz